the cliff
Patent cliff
Drugs ranked by the soonest barrier to generic / biosimilar entry. Each row shows the earliest-expiring patent OR FDA exclusivity for that drug — whichever falls first determines when competitive pressure begins.
- Sep 4, 20348.0ypatentRyaltris(mometasone furoate + olopatadine hydrochloride)Hikma Pharmaceuticals USA Inc
- Nov 21, 20348.2ypatentDEFERASIROXDEFERASIROXReddy US Therapeutics Inc
- Jan 30, 20358.4ypatentVasostrictvasopressinPar Pharmaceutical Inc
- Feb 25, 20358.5ypatentBrynovinsitagliptinRevio Therapeutics LLP
- Feb 26, 20358.5ypatentNOREPINEPHRINE BITARTRATENOREPINEPHRINE BITARTRATEInforlife SA
- Feb 27, 20358.5ypatentBafiertammonomethyl fumarateCycle Pharmaceuticals Ltd
- Mar 13, 20358.5ypatentVancomycin Hydrochloridevancomycin hydrochlorideSamson Medical Technologies LLC
- Mar 26, 20358.5ypatentPemfexypemetrexed [INN]Eagle Pharmaceuticals Inc
- Apr 21, 20358.6ypatenthydrogen peroxideKortuc Japan LLC
- May 29, 20358.7ypatentISOTRETINOINISOTRETINOINAmneal Pharmaceuticals of New York LLC
- Jun 26, 20358.8ypatentCyclophosphamidecyclophosphamide [INN]Long Grove Pharmaceuticals LLC
- Jul 9, 20358.8ypatentToprol-XLmetoprolol succinateMelinta Therapeutics LLC
- Oct 19, 20359.1ypatentVARENICLINE TARTRATEVARENICLINE TARTRATEOyster Point Pharma Inc
- Nov 6, 20359.1ypatentLisinoprillisinoprilCorePharma LLC
- Nov 13, 20359.2ypatentElixsure EXguaifenesinMoberg Pharma AB
- Dec 2, 20359.2ypatentArakodatafenoquine succinate$SXTP60 DEGREES PHARMACEUTICALS, INC.
- Jan 19, 20369.3ypatentTascenso ODTfingolimod [INN]Cycle Pharmaceuticals Ltd
- Feb 12, 20369.4ypatentRosuvastatin Calciumrosuvastatin calciumTeva Pharmaceuticals USA Inc
- Feb 16, 20369.4ypatentGvokeglucagon [INN]$XERSXeris Biopharma Holdings, Inc.
- Apr 21, 20369.6ypatentLansoprazolelansoprazoleNATCO Pharma Inc.
sourced from FDA Orange Book · approved drugs only · biologics + biosimilars excluded (those live in the Purple Book — coming soon)